Histamine and H1-antihistamines: Celebrating a century of progress

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 6, 2011, Pages

  Simons, F Estelle R ^a   Simons, Keith J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

alcaftadine; allergic conjunctivitis; allergic rhinitis; atopic dermatitis; bepotastine; bilastine; cetirizine; desloratadine; fexofenadine; Histamine; levocetirizine; loratadine; rupatadine; urticaria

Indexed keywords

ALCAFTADINE; AZELASTINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETOTASTINE; BILASTINE; CETIRIZINE; CHLORPHENIRAMINE; CIMETIDINE; DESLORATADINE; DIPHENHYDRAMINE; DOXEPIN; ECALLANTIDE; EMEDASTINE; EPINASTINE; FAMOTIDINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; ICATIBANT; KETOTIFEN; KETOTIFEN FUMARATE; LEVOCABASTINE; LEVOCETIRIZINE; LORATADINE; MEPYRAMINE MALEATE; NIZATIDINE; OLOPATADINE; PSEUDOEPHEDRINE; RANITIDINE; RUPATADINE; UNINDEXED DRUG; ANTIALLERGIC AGENT;

AGITATION; AKATHISIA; ALERTNESS; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; ANXIETY; ASTHMA; ATOPIC DERMATITIS; ATTENTION DISTURBANCE; CHRONIC URTICARIA; COGNITION; COGNITIVE DEFECT; COLD URTICARIA; COMMON COLD; CONFUSION; CONSCIOUS SEDATION; CONSTIPATION; DROWSINESS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRY EYE; DYSTONIA; FATIGUE; GASTROESOPHAGEAL REFLUX; HALLUCINATION; HEADACHE; HUMAN; IMMUNOREGULATION; INCREASED APPETITE; INSOMNIA; LEARNING DISORDER; MEMORY DISORDER; MIGRAINE; MOTION SICKNESS; MYDRIASIS; OTITIS MEDIA; PEPTIC ULCER; PRIORITY JOURNAL; QUALITY OF LIFE; RECEPTOR OCCUPANCY; REM SLEEP; REVIEW; SIDE EFFECT; SINUS TACHYCARDIA; SINUSITIS; SOMNOLENCE; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT RESPONSE; URINE RETENTION; URTICARIA; VERTIGO; WEIGHT GAIN; XEROSTOMIA; HISTORY; HYPERSENSITIVITY;

ANTI-ALLERGIC AGENTS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPERSENSITIVITY;

EID: 82555168341     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.09.005     Document Type: Review

References (134)

1. 1-antihistamines N Engl J Med 351 2004 2203 2217
2. A. Windaus, and W. Vogt Synthese des imidazolylethylamines Ber Dtsch Chem Ges 3 1907 3691 3695
3. H.H. Dale, and P.P. Laidlaw The physiological action of beta-iminazolylethylamine J Physiol 41 1910 318 344
4. D. Bovet, and A. Staub Action protectrice des éthers phénoliques au cours de l'intoxication histaminique CRS Soc Biol (Paris) 124 1937 527 549
5. B.N. Halpern Les antihistaminiques de synthse: essai de chimiothérapie des états allergiques Arch Int Pharmacodyn Ther 68 1942 339 345
6. E.R. Loew, R. MacMillan, and M.E. Kaiser The anti-histamine properties of Benadryl, β-dimethylaminoethyl benzhydryl ether hydrochloride J Pharmacol Exp Ther 86 1946 229 238
7. J.B. Wyngaarden, and M.H. Seevers The toxic effects of antihistaminic drugs JAMA 145 1951 277 282
8. O. Arunlakshana Histamine release by antihistamines J Physiol 119 1953 47P 48P
9. G. Kagan, E. Dabrowicki, L. Huddlestone, T.R. Kapur, and P. Wolstencroft A double-blind trial of terfenadine and placebo in hay fever using a substitution technique for non-responders J Int Med Res 8 1980 404 407 (Pubitemid 11230130)
10. P. Panula, H.Y. Yang, and E. Costa Histamine-containing neurons in the rat hypothalamus Proc Natl Acad Sci U S A 81 1984 2572 2576
11. I. Gantz, M. Schäffer, J. DelValle, C. Logsdon, V. Campbell, and M. Uhler Molecular cloning of a gene encoding the histamine H2 receptor Proc Natl Acad Sci U S A 88 1991 429 433 (Pubitemid 21915478)
12. M.D. De Backer, W. Gommeren, H. Moereels, G. Nobels, P. Van Gompel, and J.E. Leysen Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor Biochem Biophys Res Commun 197 1993 1601 1608 (Pubitemid 24042807)
13. 3 receptor Mol Pharmacol 55 1999 1101 1107 (Pubitemid 29252378)
14. T. Oda, N. Morikawa, Y. Saito, Y. Masuho, and S. Matsumoto Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes J Biol Chem 275 2000 36781 36786 (Pubitemid 32002087)
15. 1 receptor antagonists Eur J Pharmacol 387 2000 R5 R7 (Pubitemid 30035384)
16. q/11-subunits in constitutive and agonist-mediated signaling Mol Pharmacol 60 2001 1133 1142 (Pubitemid 33027449)
17. R. Leurs, H.F. Vischer, M. Wijtmans, and I.J.P. de Esch En route to new blockbuster antihistamines: surveying the offspring of the expanding histamine receptor family Trends Pharmacol Sci 32 2011 250 257
18. 1-antihistamines N.F. Adkinson Jr. B.S. Bochner, W.W. Busse, S.T. Holgate, R.F. Lemanske Jr. F.E.R. Simons, Middleton's allergy: principles and practice 7th ed. 2009 Mosby (an affiliate of Elsevier Science) St Louis 1517 1548
19. H.L. Haas, O.A. Sergeeva, and O. Selbach Histamine in the nervous system Physiol Rev 88 2008 1183 1241
20. M.M. Thakkar Histamine in the regulation of wakefulness Sleep Med Rev 15 2011 65 74
21. S. Nijmeijer, R. Leurs, and H.F. Vischer Constitutive activity of the histamine H(1) receptor Methods Enzymol 484 2010 127 147
22. T. Shimamura, M. Shiroishi, S. Weyand, H. Tsujimoto, G. Winter, and V. Katritch Structure of the human histamine H1 receptor complex with doxepin Nature 475 2011 65 70
23. S.J. Keam, and G.L. Plosker Rupatadine: a review of its use in the management of allergic disorders Drugs 67 2007 457 474 (Pubitemid 46437100)
24. M.K. Church Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males Br J Dermatol 163 2010 1330 1332
25. F. Horak, P. Zieglmayer, R. Zieglmayer, and P. Lemell The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber Inflamm Res 59 2010 391 398
26. F.C. Hampel, P.H. Ratner, J. Van Bavel, N.J. Amar, P. Daftary, and W. Wheeler Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device Ann Allergy Asthma Immunol 105 2010 168 173
27. 1- antihistamine Med Lett Drugs Ther 52 2010 11 12
28. H. Bohets, C. McGowan, G. Mannens, N. Schroeder, K. Edwards-Swanson, and A. Shapiro Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis J Ocul Pharmacol Ther 27 2011 187 195
29. A. Lambiase, A. Micera, and S. Bonini Multiple action agents and the eye: do they really stabilize mast cells? Curr Opin Allergy Clin Immunol 9 2009 454 465
30. K. Weller, and M. Maurer Desloratadine inhibits human skin mast cell activation and histamine release J Invest Dermatol 129 2009 2723 2726
31. K. Yanai, D. Zhang, M. Tashiro, T. Yoshikawa, F. Naganuma, and R. Harada Positron emission tomography evaluation of sedative properties of antihistamines Expert Opin Drug Saf 10 2011 613 622
32. D. Zhang, M. Tashiro, K. Shibuya, N. Okamura, Y. Funaki, and T. Yoshikawa Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography J Clin Psychopharmacol 30 2010 694 701
33. 2LEN position paper Allergy 65 2010 459 466
34. P. Devillier, N. Roche, and C. Faisy Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine: a comparative review Clin Pharmacokinet 47 2008 217 230 (Pubitemid 351367433)
35. M. Miura, and T. Uno Clinical pharmacokinetics of fexofenadine enantiomers Expert Opin Drug Metab Toxicol 6 2010 69 74
36. D.G. Bailey Fruit juice inhibition of uptake transport: a new type of food-drug interaction Br J Clin Pharmacol 70 2010 645 655
37. H. Phan, M.L. Moeller, and M.C. Nahata Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast Drugs 69 2009 2541 2576
38. D.H. Jones, F.A. Romero, and T.B. Casale Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine Ann Allergy Asthma Immunol 100 2008 452 456 (Pubitemid 351668781)
39. N. Frossard, M. Strolin-Benedetti, A. Purohit, and G. Pauli Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine Br J Clin Pharmacol 65 2008 172 179 (Pubitemid 351171271)
40. S. Gillman, M. Gillard, and M. Strolin Benedetti The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines Allergy Asthma Proc 30 2009 366 376
41. 1-receptor occupancy to antihistamine dosing in children J Allergy Clin Immunol 119 2007 1551 1554 (Pubitemid 46855868)
42. Anonymous Drugs for allergic disorders Treat Guide Med Lett 9 2010 9 18
43. J.L. Brozek, J. Bousquet, C.E. Baena-Cagnani, S. Bonini, G.W. Canonica, and T.B. Casale Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision J Allergy Clin Immunol 126 2010 466 476
44. F.C.L. Hoyte, and R.K. Katial Antihistamine therapy in allergic rhinitis Immunol Allergy Clin North Am 31 2011 509 543
45. G.K. Scadding, S.R. Durham, R. Mirakian, N.S. Jones, S.C. Leech, and S. Farooque BSACI guidelines for the management of allergic and non-allergic rhinitis Clin Exp Allergy 38 2008 19 42 (Pubitemid 350233401)
46. D.V. Wallace, M.S. Dykewicz, D.I. Bernstein, J. Blessing-Moore, L. Cox, and D.A. Khan The diagnosis and management of rhinitis: an updated practice parameter J Allergy Clin Immunol 122 suppl 2008 S1 S84 (Pubitemid 352033573)
47. L. Bielory, and M.H. Friedlaender Allergic conjunctivitis Immunol Allergy Clin North Am 28 2008 43 58 (Pubitemid 351241107)
48. 2LEN/EDF/WAO guideline: management of urticaria Allergy 64 2009 1427 1443
49. M.K. Church, K. Weller, P. Stock, and M. Maurer Chronic spontaneous urticaria in children: itching for insight Pediatr Allergy Immunol 22 2011 1 8
50. 2LEN study Int Arch Allergy Immunol 153 2010 395 402
51. G.W. Canonica, F. Fumagalli, L. Guerra, I. Baiardini, E. Compalati, and A. Rogkakou Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study Curr Med Res Opin 24 2008 2829 2839
52. C. Bachert A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis Clin Ther 31 2009 921 944
53. R.E. Grubbe, W.R. Lumry, and R. Anolik Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis J Investig Allergol Clin Immunol 19 2009 117 124
54. M. Benninger, J.R. Farrar, M. Blaiss, B. Chipps, B. Ferguson, and J. Krouse Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class Ann Allergy Asthma Immunol 104 2010 13 29
55. J.W. Hay, and M.A. Kaliner Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective Curr Med Res Opin 25 2009 1421 1431
56. A.N. Greiner, and E.O. Meltzer Overview of the treatment of allergic rhinitis and nonallergic rhinopathy Proc Am Thorac Soc 8 2011 121 131
57. J. Bousquet, C. Bachert, G.W. Canonica, T.B. Casale, A.A. Cruz, and R.J. Lockey Unmet needs in severe chronic upper airway disease (SCUAD) J Allergy Clin Immunol 124 2009 428 433
58. M.A. Kaliner, W.E. Berger, P.H. Ratner, and C.J. Siegel The efficacy of intranasal antihistamines in the treatment of allergic rhinitis Ann Allergy Asthma Immunol 106 suppl 2011 S6 S11
59. S.R. Shah, A. Nayak, P. Ratner, P. Roland, and G. Michael Wall Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults Clin Ther 31 2009 99 107
60. P. Lieberman, E.O. Meltzer, C.F. LaForce, A.L. Darter, and M.J. Tort Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis Allergy Asthma Proc 32 2011 151 158
61. J.V. Greiner, K. Edwards-Swanson, and A. Ingerman Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1% Clin Ophthalmol 5 2011 87 93
62. M.B. Abelson, G.L. Torkildsen, J.I. Williams, J.A. Gow, P.J. Gomes, and T.R. McNamara Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children Clin Ther 31 2009 1908 1921
63. G.L. Torkildsen, J.I. Williams, J.A. Gow, P.J. Gomes, M.B. Abelson, and T.R. McNamara Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge Ann Allergy Asthma Immunol 105 2010 57 64
64. 1-antihistamine treatment in young atopic children: effect on urticaria Ann Allergy Asthma Immunol 99 2007 261 266 (Pubitemid 47417228)
65. P.C. Potter, A. Kapp, M. Maurer, G. Guillet, A.M. Jian, and P. Hauptmann Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients Allergy 64 2009 596 604
66. A. Gimenez-Arnau, I. Izquierdo, and M. Maurer The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg J Eur Acad Dermatol Venereol 23 2009 1088 1091
67. T. Zuberbier, A. Oanta, E. Bogacka, I. Medina, F. Wesel, and P. Uhl Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study Allergy 65 2010 516 528
68. M. Staevska, T.A. Popov, T. Kralimarkova, C. Lazarova, S. Kraeva, and D. Popova The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria J Allergy Clin Immunol 125 2010 676 682
69. T. Zuberbier Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses J Eur Acad Dermatol Venereol 2011 [Epub ahead of print]
70. F. Siebenhaar, F. Degener, T. Zuberbier, P. Martus, and M. Maurer High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study J Allergy Clin Immunol 123 2009 672 679
71. M. Metz, E. Scholz, M. Ferran, I. Izquierdo, A. Gimenez-Arnau, and M. Maurer Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria Ann Allergy Asthma Immunol 104 2010 86 92
72. 2LEN task force report Allergy 66 2011 317 330
73. M. Arock, and P. Valent Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives Expert Rev Hematol 3 2010 497 516
74. A. Karppinen, H. Brummer-Korvenkontio, L. Petman, H. Kautiainen, Jean-P. Herve, and T. Reunala Levocetirizine for treatment of immediate and delayed mosquito bite reactions Acta Derm Venereol (Stockh) 86 2006 329 331 (Pubitemid 44133379)
75. U.R. Muller, M. Jutel, A. Reimers, J. Zumkehr, C. Huber, and C. Kriegel Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy J Allergy Clin Immunol 122 2008 1001 1007
76. J. Buddenkotte, M. Maurer, and M. Steinhoff Histamine and antihistamines in atopic dermatitis Adv Exp Med Biol 709 2010 73 80
77. P.J. Dunford, and S.T. Holgate The role of histamine in asthma Adv Exp Med Biol 709 2010 53 66
78. 1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review Allergy 62 2007 830 837 (Pubitemid 47037864)
79. J.H. Levy, D.J. Freiberger, and J. Roback Hereditary angioedema: current and emerging treatment options Anesth Analg 110 2010 1271 1280
80. C. Coleman, and M. Moore Decongestants and antihistamines for acute otitis media in children Cochrane Database Syst Rev 3 2008 CD001727
81. E.O. Meltzer, and D.L. Hamilos Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines Mayo Clin Proc 86 2011 427 443
82. N. Shaikh, E.R. Wald, and M. Pi Decongestants, antihistamines and nasal irrigation for acute sinusitis in children Cochrane Database Syst Rev 12 2010 CD007909
83. A.B. Chang, J. Peake, and M.S. McElrea Antihistamines for prolonged non-specific cough in children Cochrane Database Syst Rev 2 2010 CD005604
84. Williamson I. Otitis media with effusion in children. Clin Evid (Online) 2011; pii: 0502.
85. M.W. Greaves Pathogenesis and treatment of pruritus Curr Allergy Asthma Rep 10 2010 236 242
86. A.D. Krystal, H.H. Durrence, M. Scharf, P. Jochelson, R. Rogowski, and E. Ludington Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia Sleep 33 2010 1553 1561
87. C.L. Roach, N. Husain, J. Zabinsky, E. Welch, and R. Garg Moderate sedation for echocardiography of preschoolers Pediatr Cardiol 31 2010 469 473
88. G. Guaiana, C. Barbui, and A. Cipriani Hydroxyzine for generalised anxiety disorder Cochrane Database Syst Rev 12 2010 CD006815
89. Cheng-W. Lu, Wei-H. Jean, Chia-C. Wu, Jiann-S. Shieh, and Tzu-Y. Lin Antiemetic efficacy of metoclopramide and diphenhydramine added to patient-controlled morphine analgesia: a randomised controlled trial Eur J Anaesthesiol 27 2010 1052 1057
90. J.R. Niebyl Clinical practice. Nausea and vomiting in pregnancy N Engl J Med 363 2010 1544 1550
91. J.F. Golding, and M.A. Gresty Motion sickness Curr Opin Neurol 18 2005 29 34 (Pubitemid 40270262)
92. J.C. Ratliff, J.A. Barber, L.B. Palmese, E.L. Reutenauer, and C. Tek Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey Obesity (Silver Spring) 18 2010 2398 2400
93. Shang-J. Shi, S.H. Platts, M.G. Ziegler, and J.V. Meck Effects of promethazine and midodrine on orthostatic tolerance Aviat Space Environ Med 82 2011 9 12
94. S.D. St Peter, S.W. Sharp, and D.J. Ostlie Influence of histamine receptor antagonists on the outcome of perforated appendicitis: analysis from a prospective trial Arch Surg 145 2010 143 146
95. M. Metz Effects of antihistamines on innate immune responses to severe bacterial infection in mice Int Arch Allergy Immunol 155 2011 355 360
96. 1 receptor occupancy and proportional impairment ratio Hum Psychopharmacol 26 2011 133 139
97. 11C-doxepin Hum Psychopharmacol 24 2009 540 548
98. 11C-doxepin Br J Clin Pharmacol 65 2008 811 821 (Pubitemid 351695231)
99. J. Officer Trends in drug use of Scottish drivers arrested under Section 4 of the Road Traffic Act - a 10 year review Sci Justice 49 2009 237 241
100. X. Zhuo, Y. Cang, H. Yan, J. Bu, and B. Shen The prevalence of drugs in motor vehicle accidents and traffic violations in Shanghai and neighboring cities Accid Anal Prev 42 2010 2179 2184
101. A. Sen, A. Akin, K.J. Craft, D.V. Canfield, and A.K. Chaturvedi First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005 Aviat Space Environ Med 78 2007 514 522 (Pubitemid 46717245)
102. J. Boyle, M. Eriksson, N. Stanley, T. Fujita, and Y. Kumagi Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects Curr Med Res Opin 22 2006 1343 1351 (Pubitemid 44085586)
103. K. McDonald, L. Trick, and J. Boyle Sedation and antihistamines: an update. Review of inter-drug differences using proportional impairment ratios Hum Psychopharmacol 23 2008 555 570
104. S. Conen, E.L. Theunissen, A. Vermeeren, and J.G. Ramaekers Short-term effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteers J Clin Psychopharmacol 31 2011 294 301
105. A. Thomas, D.G. Nallur, N. Jones, and P.N. Deslandes Diphenhydramine abuse and detoxification: a brief review and case report J Psychopharmacol 23 2009 101 105
106. M. Kurella Tamura, B. Larive, M.L. Unruh, J.B. Stokes, A. Nissenson, and R.L. Mehta Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials Clin J Am Soc Nephrol 5 2010 1429 1438
107. W.J. Meurer, T.A. Potti, K.A. Kerber, C. Sasson, M.L. Macy, and B.T. West Potentially inappropriate medication utilization in the emergency department visits by older adults: analysis from a nationally representative sample Acad Emerg Med 17 2010 231 237
108. C.-M. Chang, M.-J. Chen, C.-Y. Tsai, L.-H. Ho, H.-L. Hsieh, and Y.-L. Chau Medical conditions and medications as risk factors of falls in the inpatient older people: a case-control study Int J Geriatr Psychiatry 26 2011 602 607
109. L.K. McEvoy, M.E. Smith, M. Fordyce, and A. Gevins Characterizing impaired functional alertness from diphenhydramine in the elderly with performance and neurophysiologic measures Sleep 29 2006 957 966
110. C. Weber-Schoendorfer, and C. Schaefer The safety of cetirizine during pregnancy. A prospective observational cohort study Reprod Toxicol 26 2008 19 23
111. E.B. Schwarz, M.E. Moretti, S. Nayak, and G. Koren Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis Drug Saf 31 2008 775 788
112. T. Takano, Y. Sakaue, T. Sokoda, C. Sawai, S. Akabori, and Y. Maruo Seizure susceptibility due to antihistamines in febrile seizures Pediatr Neurol 42 2010 277 279
113. Z.P. Vassilev, S. Kabadi, and R. Villa Safety and efficacy of over-the-counter cough and cold medicines for use in children Expert Opin Drug Saf 9 2010 233 242
114. N. Shehab, M.K. Schaefer, S.R. Kegler, and D.S. Budnitz Adverse events from cough and cold medications after a market withdrawal of products labeled for infants Pediatrics 126 2010 1100 1107
115. M.E. Rimsza, and S. Newberry Unexpected infant deaths associated with use of cough and cold medications Pediatrics 122 2008 e318 e322
116. R.C. Dart, I.M. Paul, G.R. Bond, D.C. Winston, A.S. Manoguerra, and R.B. Palmer Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications Ann Emerg Med 53 2009 411 417
117. J.W. Turner Death of a child from topical diphenhydramine Am J Forensic Med Pathol 30 2009 380 381
118. A.M. Nia, U. Fuhr, N. Gassanov, E. Erdmann, and F. Er Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine Eur J Clin Pharmacol 66 2010 1173 1175
119. Sang-J. Park, Ki-S. Kim, and Eun-J. Kim Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656 J Appl Toxicol 28 2008 104 111 (Pubitemid 351428282)
120. Su-H. Jo, Hee-K. Hong, S.H. Chong, H.S. Lee, and H. Choe H(1) antihistamine drug promethazine directly blocks hERG K(+) channel Pharmacol Res 60 2009 429 437
121. B.E. Benson, M.F. Farooqi, W. Klein-Schwartz, T. Litovitz, A.N. Webb, and D.J. Borys Diphenhydramine dose-response: a novel approach to determine triage thresholds Clin Toxicol (Phila) 48 2010 820 831
122. V. Sugyani Bebarta, H.W. Blair, D.L. Morgan, J. Maddry, and D.J. Borys Validation of the American Association of Poison Control Centers out of hospital guideline for pediatric diphenhydramine ingestions Clin Toxicol (Phila) 48 2010 559 562
123. C. Garcia-Gea, M.R. Ballester, J. Martinez, R.M. Antonijoan, E. Donado, and I. Izquierdo Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study Br J Clin Pharmacol 69 2010 663 674
124. R. Hulhoven, D. Rosillon, M. Letiexhe, Marie-A. Meeus, A. Daoust, and A. Stockis Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study Eur J Clin Pharmacol 63 2007 1011 1017 (Pubitemid 47561809)
125. E. Donado, I. Izquierdo, I. Perez, O. Garcia, R.M. Antonijoan, and I. Gich No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a "thorough QT/QTc study" performed according to ICH guidelines Br J Clin Pharmacol 69 2010 401 410
126. F.E.R. Simons Early Prevention of Asthma in Atopic Children (EPAAC) Study Group Safety of levocetirizine treatment in young atopic children: an 18-month study Pediatr Allergy Immunol 18 2007 535 542 (Pubitemid 47206747)
127. G. Beaton, and W.J. Moree The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005-2010 Expert Opin Ther Pat 20 2010 1197 1218
128. F. Yu, P. Bonaventure, and R.L. Thurmond The future antihistamines: histamine H3 and H4 receptor ligands Adv Exp Med Biol 709 2010 125 140
129. D. Lazewska, and K. Kiec-Kononowicz Recent advances in histamine H3 receptor antagonists/inverse agonists Expert Opin Ther Pat 20 2010 1147 1169
130. 3 receptor antagonist in a nasal allergen challenge model J Allergy Clin Immunol 125 2010 AB191
131. J.-F. Huang, and R.L. Thurmond The new biology of histamine receptors Curr Allergy Asthma Rep 8 2008 21 27 (Pubitemid 351459689)
132. J.M. Cowden, J.P. Riley, J.Y. Ma, R.L. Thurmond, and P.J. Dunford Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines Respir Res 11 2010 86
133. 4 receptor: Targeting inflammatory disorders Eur J Pharmacol 668 2011 1 5
134. 4 receptor in immune and inflammatory disorders Br J Pharmacol 157 2009 24 33